Clinical Trial Results: Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating POS for improving distance-corrected near visual acuity in presbyopia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• POS

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Presbyopia | Phase 3 | Status: COMPLETED | Results posted: 2026-08-17